BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright: ©Author(s) 2026.
World J Methodol. Sep 20, 2026; 16(3): 118520
Published online Sep 20, 2026. doi: 10.5662/wjm.118520
Table 2 Mechanisms of anti-obesity drug-induced visual impairment
Mechanism
Description
Examples
VascularIschemia due to altered ocular blood flow or microvascular injuryGLP-1 receptor agonists (NAION)
MetabolicIndirect effects, such as rapid glycemic improvement or hepatic dysfunctionGLP-1 receptor agonists (DR)
Direct drug toxicityPhysical or chemical injury to ocular structuresTopiramate (anatomic shift, effusion)


Write to the Help Desk